| PTO Form 1581 (Rev 9/2005) |
| OMB No. 0651-0054 (Exp. 09/30/2011) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
| SERIAL NUMBER |
78594746 |
| LAW OFFICE ASSIGNED |
LAW OFFICE 114 |
| MARK SECTION |
| STANDARD CHARACTERS |
NO |
| USPTO-GENERATED IMAGE |
NO |
| OWNER SECTION (current) |
| NAME |
Amylin Pharmaceuticals, Inc. |
| STREET |
9360 Towne Centre Drive |
| CITY |
San Diego |
| STATE |
California |
| ZIP/POSTAL CODE |
92121 |
| COUNTRY |
United States |
| PHONE |
858-552-2200 |
| FAX |
858-552-1936 |
| OWNER SECTION (proposed) |
| NAME |
Amylin Pharmaceuticals, Inc. |
| STREET |
9360 Towne Centre Drive |
| CITY |
San Diego |
| STATE |
California |
| ZIP/POSTAL CODE |
92121 |
| COUNTRY |
United States |
| PHONE |
858-552-2200 |
| FAX |
858-552-1936 |
| EMAIL |
XXXX |
| GOODS AND/OR SERVICES SECTION |
| INTERNATIONAL CLASS |
005 |
| CURRENT IDENTIFICATION |
Pharmaceutical preparations, namely pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, endocrine
conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders, obesity, cardiovascular diseases and disorders, gastrointestinal disorders, immunological disorders,
inflammation and inflammatory diseases, neurological disorders, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, urological disorders |
| GOODS OR SERVICES |
KEEP ALL LISTED |
| EXTENSION SECTION |
| EXTENSION NUMBER |
3 |
| ONGOING EFFORT |
product or service research development |
| ALLOWANCE MAIL DATE |
03/28/2006 |
| STATEMENT OF USE |
NO |
| PAYMENT SECTION |
| NUMBER OF CLASSES |
1 |
| SUBTOTAL AMOUNT |
150 |
| TOTAL AMOUNT |
150 |
| SIGNATURE SECTION |
| SIGNATURE |
/Kenneth Barovsky/ |
| SIGNATORY'S NAME |
Kenneth Barovsky, J.D., Ph.D. |
| SIGNATORY'S POSITION |
Senior Director Intellectual Property |
| DATE SIGNED |
09/10/2007 |
| FILING INFORMATION |
| SUBMIT DATE |
Mon Sep 10 16:26:30 EDT 2007 |
| TEAS STAMP |
USPTO/ESU-XX.XXX.XX.X-200
70910162630223598-7859474
6-4009deb89a7ec5ea3fa2065
34c152e07b79-DA-1394-2007
0910133818666291 |
| PTO Form 1581 (Rev 9/2005) |
| OMB No. 0651-0054 (Exp. 09/30/2011) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: NUZENDIS (stylized and/or with design)
SERIAL NUMBER: 78594746
The applicant, Amylin Pharmaceuticals, Inc., having an address of 9360 Towne Centre Drive, San Diego, California United States 92121, requests a six-month extension of time to file the Statement of
Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 03/28/2006.
For International Class 005:
Current identification: Pharmaceutical preparations, namely pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, endocrine conditions and disorders, diabetes,
diabetic complications, hormonal diseases and disorders, obesity, cardiovascular diseases and disorders, gastrointestinal disorders, immunological disorders, inflammation and inflammatory diseases,
neurological disorders, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, urological disorders
The applicant has a continued bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with all of the goods and/or services
listed in the Notice of Allowance or as subsequently modified for this specific class.
This is the third extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods and/or services covered by
the extension request: product or service research development
A fee payment in the amount of $150 will be submitted with the form, representing payment for 1 class.
Declaration
The undersigned being hereby warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements
and the like may jeopardize the validity of this document, declares that he/she is properly authorized to execute this document on behalf of the Owner; and all statements made of his/her own
knowledge are true and that all statements made on information and belief are believed to be true.
Signature: /Kenneth Barovsky/ Date Signed: 09/10/2007
Signatory's Name: Kenneth Barovsky, J.D., Ph.D.
Signatory's Position: Senior Director Intellectual Property
RAM Sale Number: 1394
RAM Accounting Date: 09/11/2007
Serial Number: 78594746
Internet Transmission Date: Mon Sep 10 16:26:30 EDT 2007
TEAS Stamp: USPTO/ESU-XX.XXX.XX.X-200709101626302235
98-78594746-4009deb89a7ec5ea3fa206534c15
2e07b79-DA-1394-20070910133818666291